Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jun Toyohara; Mohammed Al-Qahtani; Ya Yao Huang; Emiliano Cazzola; Sergio Todde; Shozo Furumoto; Renata Mikolajczak; Antonia Denkova; Yann Seimbille

doi:10.1186/s41181-022-00177-w

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Jun Toyohara, Mohammed Al-Qahtani, Ya Yao Huang, Emiliano Cazzola, Sergio Todde, Shozo Furumoto, Renata Mikolajczak, Antonia Denkova, Yann Seimbille

RST/Applied Radiation & Isotopes

Research output: Contribution to journal › Review article › peer-review

56 Downloads (Pure)

Abstract

Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

Original language	English
Article number	25
Number of pages	18
Journal	EJNMMI Radiopharmacy and Chemistry
Volume	7
Issue number	1
DOIs	https://doi.org/10.1186/s41181-022-00177-w
Publication status	Published - 2022

Keywords

Highlight Articles
Nuclear Medicine
Radiochemistry
Radiopharmaceutical Sciences
Radiopharmacy
Trends in Radiopharmaceutical Sciences

Access to Document

10.1186/s41181-022-00177-w

s41181-022-00177-wFinal published version, 1.52 MBLicence: CC BY

Cite this

@article{cb48660bc8f749d38fc279eae0790bde,

title = "Highlight selection of radiochemistry and radiopharmacy developments by editorial board",

abstract = "Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.",

keywords = "Highlight Articles, Nuclear Medicine, Radiochemistry, Radiopharmaceutical Sciences, Radiopharmacy, Trends in Radiopharmaceutical Sciences",

author = "Jun Toyohara and Mohammed Al-Qahtani and Huang, {Ya Yao} and Emiliano Cazzola and Sergio Todde and Shozo Furumoto and Renata Mikolajczak and Antonia Denkova and Yann Seimbille",

year = "2022",

doi = "10.1186/s41181-022-00177-w",

language = "English",

volume = "7",

journal = "EJNMMI Radiopharmacy and Chemistry",

issn = "2365-421X",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Highlight selection of radiochemistry and radiopharmacy developments by editorial board

AU - Toyohara, Jun

AU - Al-Qahtani, Mohammed

AU - Huang, Ya Yao

AU - Cazzola, Emiliano

AU - Todde, Sergio

AU - Furumoto, Shozo

AU - Mikolajczak, Renata

AU - Denkova, Antonia

AU - Seimbille, Yann

PY - 2022

Y1 - 2022

N2 - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

AB - Background: The Editorial Board of EJNMMI Radiopharmacy and Chemistry releases a biannual highlight commentary to update the readership on trends in the field of radiopharmaceutical development. Main Body: This commentary of highlights has resulted in 21 different topics selected by each coauthoring Editorial Board member addressing a variety of aspects ranging from novel radiochemistry to first in man application of novel radiopharmaceuticals. Conclusion: Trends in radiochemistry and radiopharmacy are highlighted demonstrating the progress in the research field in various topics including new PET-labelling methods, FAPI-tracers and imaging, and radionuclide therapy being the scope of EJNMMI Radiopharmacy and Chemistry.

KW - Highlight Articles

KW - Nuclear Medicine

KW - Radiochemistry

KW - Radiopharmaceutical Sciences

KW - Radiopharmacy

KW - Trends in Radiopharmaceutical Sciences

UR - http://www.scopus.com/inward/record.url?scp=85139381904&partnerID=8YFLogxK

U2 - 10.1186/s41181-022-00177-w

DO - 10.1186/s41181-022-00177-w

M3 - Review article

AN - SCOPUS:85139381904

SN - 2365-421X

VL - 7

JO - EJNMMI Radiopharmacy and Chemistry

JF - EJNMMI Radiopharmacy and Chemistry

IS - 1

M1 - 25

ER -

Highlight selection of radiochemistry and radiopharmacy developments by editorial board

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this